Chong Kun Dang Pharmaceutical Corp. (KRX:185750)

Market Cap	1.04T
Revenue (ttm)	1.69T +6.7%
Net Income	77.51B -28.9%
EPS	5,845.54 -29.0%
Shares Out	13.18M
PE Ratio	13.48
Forward PE	14.14
Dividend	1,100.00 (1.38%)
Ex-Dividend Date	Dec 29, 2025

Volume	29,031
Open	79,900
Previous Close	79,800
Day's Range	78,200 - 80,100
52-Week Range	78,000 - 106,800
Beta	0.29
Analysts	Buy
Price Target	119,166.67 (+51.23%)
Earnings Date	May 4, 2026

About KRX:185750

Chong Kun Dang Pharmaceutical Corp. manufactures, markets, and sells medicines in South Korea and internationally. It offers prescription drugs for anti-hypertension, anti-hyperlipidaemia, and anti-diabetics, as well as immunosuppressants; over-the-counter medicines; and consumer health products, such as insecticides and hair dye products, as well as health supplements. The company was founded in 1941 and is headquartered in Seoul, South Korea.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1941
• Employees: 2,253
• Stock Exchange: Korea Stock Exchange
• Ticker Symbol: 185750

Financial Performance

In 2025, KRX:185750's revenue was 1.69 trillion, an increase of 6.68% compared to the previous year's 1.59 trillion. Earnings were 77.51 billion, a decrease of -28.94%.